Good response to tumour necrosis factor alpha blockade results in an angiogenic T cell recovery in rheumatoid arthritis patients

Rheumatology (Oxford). 2015 Jun;54(6):1129-31. doi: 10.1093/rheumatology/kev025. Epub 2015 Mar 31.

Authors

Javier Rodríguez-Carrio¹, Mercedes Alperi-López², Patricia López², Francisco J Ballina-García², Ana Suárez¹

Affiliations

¹ Area of Immunology, Department of Functional Biology, Faculty of Medicine, University of Oviedo and Department of Rheumatology, Hospital Universitario Central de Asturias, Oviedo, Spain anasua@uniovi.es.
² Area of Immunology, Department of Functional Biology, Faculty of Medicine, University of Oviedo and Department of Rheumatology, Hospital Universitario Central de Asturias, Oviedo, Spain.

PMID: 25832609
DOI: 10.1093/rheumatology/kev025

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Arthritis, Rheumatoid / drug therapy*
Endothelial Progenitor Cells / drug effects*
Female
Humans
Longitudinal Studies
Male
Middle Aged
T-Lymphocytes / drug effects*
Treatment Outcome
Tumor Necrosis Factor-alpha / drug effects*

Substances

Tumor Necrosis Factor-alpha